Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AIM ImmunoTech (AIM) Assets (2018 - 2025)

Historic Assets for ImmunoTech (AIM) over the last 11 years, with Q3 2025 value amounting to $5.5 million.

  • ImmunoTech's Assets fell 5956.73% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year decrease of 5956.73%. This contributed to the annual value of $8.6 million for FY2024, which is 5558.54% down from last year.
  • Latest data reveals that ImmunoTech reported Assets of $5.5 million as of Q3 2025, which was down 5956.73% from $4.1 million recorded in Q2 2025.
  • In the past 5 years, ImmunoTech's Assets ranged from a high of $33.6 million in Q2 2023 and a low of $4.1 million during Q2 2025
  • Its 3-year average for Assets is $15.1 million, with a median of $14.7 million in 2024.
  • Per our database at Business Quant, ImmunoTech's Assets plummeted by 5122.93% in 2024 and then tumbled by 7372.57% in 2025.
  • Over the past 3 years, ImmunoTech's Assets (Quarter) stood at $19.4 million in 2023, then tumbled by 55.59% to $8.6 million in 2024, then plummeted by 36.18% to $5.5 million in 2025.
  • Its Assets was $5.5 million in Q3 2025, compared to $4.1 million in Q2 2025 and $6.2 million in Q1 2025.